(Reuters) -Medtronic Plc said on Thursday it was stopping the sale and distribution of one of its heart pumps due to safety concerns, sending its shares down about 1% in premarket trading. The ...

Company Has Initiated a Post-Approval Study of Heart Failure Management Best Practices to Further Demonstrate Improved Patient Outcomes DUBLIN and ORLANDO, Fla. - April 5, 2019 - Medtronic plc ...

Health care providers should no longer use Medtronic’s Heartware Ventricular Assist Device (HVAD) System in end-stage heart failure patients. The Food and Drug Administration (FDA) is notifying health ...

- Medtronic Coordinating with Global Regulators to Assure Patient Access to Left Ventricular Assist Devices DUBLIN, June 3, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical ...

Medtronic is stopping the sale and distribution of its embattled HVAD system. The Dublin-based company said it initiated this action in light of a growing body of observational clinical comparisons ...

(RTTNews) - Medical devices maker Medtronic plc (MDT) will stop the distribution and sale of the Medtronic Heartware Ventricular Assist Device (HVAD) System. It has also notified physicians to cease ...

DUBLIN., The United States Food and Drug Administration (FDA) has classified Medtronic plc's recent voluntary urgent field action related to the HeartWare(TM) HVAD(TM) System unexpected power source ...

The US Food and Drug Administration (FDA) has classified a recent field action undertaken by Medtronic for their HeartWare HVAD system as a Class I recall. Last month, Medtronic issued an alert to ...

Medtronic has issued a recall of the controller driveline cover of the company's HeartWare Ventricular Assist Device (HVAD) system. The Medtronic HVAD system was approved as a bridge to heart ...